Modular Medical, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
Modular Medical, Inc. announced FDA clearance for its Pivot insulin delivery system, marking a significant step towards commercialization and broader market adoption.
NASDAQ
Modular Medical, Inc., a pre-revenue medical device company, has received FDA clearance for its MODD1 insulin pump and plans initial shipments by September 2025, while acknowledging substantial doubt about its ability to continue as a going concern without further capital.
NASDAQ
Modular Medical's amended and restated 2017 Equity Incentive Plan aims to attract and retain top talent while promoting the company's success.